Cargando…
Cardiac repair in a murine model of myocardial infarction with human induced pluripotent stem cell-derived cardiomyocytes
BACKGROUND: Cellular replacement strategies using human induced pluripotent stem cells (iPSCs) and their cardiac derivatives are emerging as novel treatments for post-myocardial infarction (MI) heart failure (HF); however, the mechanism of recovery of heart function is not very clear. The purpose of...
Autores principales: | Jiang, Xin, Yang, Ziyi, Dong, Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7368795/ https://www.ncbi.nlm.nih.gov/pubmed/32680540 http://dx.doi.org/10.1186/s13287-020-01811-7 |
Ejemplares similares
-
Transferrin improved the generation of cardiomyocyte from human pluripotent stem cells for myocardial infarction repair
por: Zhang, Fengzhi, et al.
Publicado: (2020) -
Strategies to improve the therapeutic effect of pluripotent stem cell-derived cardiomyocytes on myocardial infarction
por: Xiao, Yang, et al.
Publicado: (2022) -
Comparison of Non-human Primate versus Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Treatment of Myocardial Infarction
por: Zhao, Xin, et al.
Publicado: (2018) -
Cardiac Regeneration with Human Pluripotent Stem Cell-Derived Cardiomyocytes
por: Park, Misun, et al.
Publicado: (2018) -
Comparison of Human Induced Pluripotent Stem-Cell Derived Cardiomyocytes with Human Mesenchymal Stem Cells following Acute Myocardial Infarction
por: Citro, Lucas, et al.
Publicado: (2014)